Free Patent Lawyers? It’s easier than you think!

Are you a student curious if there is a place for pro bono work in patent law? Are you a practitioner curious about how the U.S. Patent and Trademark Office (USPTO) has addressed accessibility to patent protection? Do you or a friend want to file a patent for an invention but can’t afford a patent attorney?  If so, this blog is for you! Continue reading “Free Patent Lawyers? It’s easier than you think!”

Knowing Your Audience: The Importance of Venue in Patent Litigation

As a summer associate working in patent litigation, I kept seeing the same judge’s name in the same district court. At first, I had no idea why this was the case. However, I’ve since learned how important venue is in patent litigation.

Selecting the right venue is crucial in patent litigation cases, because where a case is filed can impact its likelihood of success. So, what exactly is venue? And why is it so important to patent litigation? Allow me explain.

Continue reading “Knowing Your Audience: The Importance of Venue in Patent Litigation”

The Sound of Science: Musicians Who Were Also Inventors

When people think about musicians, they usually don’t think inventor. But some musicians broke the mold when they patented their inventions. Let’s explore these true renaissance people.  We should make note of these talented folks who generally own both copyright on their music (and sound recordings) AND patents on their inventions

Continue reading “The Sound of Science: Musicians Who Were Also Inventors”

Eight Great Pumpkin Patents

Fall is here which means stores and front stoops are full of all things pumpkin! Taking IP this Fall has made me realize that many great fall items may have some kind of intellectual property (IP) protection. That’s been one of my favorite parts of learning more about IP, the realization that it truly impacts all areas of our lives. To help prove my point I rounded up some of the most interesting pumpkin related patents I could find. Continue reading “Eight Great Pumpkin Patents”

Was Harry Houdini’s Most Famous Trick Understanding IP Law?

Intellectual property (IP) law probably isn’t the first thing you think of when you think of Harry Houdini. One probably envisions dramatic performances involving straightjackets, water barrels, or sleight of hand illusions. However, Houdini’s greatest trick may have been leveraging IP to his personal advantage.

While many know of the magician for his impressive feats of escape, the Hungarian-born immigrant was also an avid inventor. Harry Houdini, born Erik Weitz, came of age during the Industrial Revolution. As a product of his time, Houdini had high esteem for feats of mechanical engineering. This, along with a few other incentives discussed later, led him to patent the machines he created for his magic performances.

He designed created new machines that would dazzle his audiences with exciting performances. Patenting his inventions served a few important functions for Houdini. But before describing those functions, let’s first explain how patents work and what they do.

Continue reading “Was Harry Houdini’s Most Famous Trick Understanding IP Law?”

In the Market for Affordable Medicines

Patents and pandemics.  At first, these two things might not seem too related.  Beyond patenting useful things for a pandemic – personal protective equipment, medicines, etc. – what do they have to do with one another?  Well, it turns out that the COVID-19 pandemic has put the spotlight on how to make patented medicines affordable.

Continue reading “In the Market for Affordable Medicines”

Incentivizing Innovation in Rare Disease Research

You might know that patents exist to incentivize innovation. In other words, the inventor who meets patent standards is given a period of market exclusivity (permitting the inventor to exclude others from various activities involving the patented invention) in exchange for publicly disclosing his/her invention. While this may be sufficient incentive for many technological areas, rare diseases pose a unique challenge.

Drug companies don’t generally target rare diseases. Why? A small patient population means that even if expensive research efforts are successful, there will not be a large return on investment. In 1983, the Orphan Drug Act (ODA) was passed with the intent to solve this problem. Has it worked? The answer to this question is more complicated than it may seem. Continue reading “Incentivizing Innovation in Rare Disease Research”